Compare AGIO & VERX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AGIO | VERX |
|---|---|---|
| Founded | 2007 | 1978 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.0B | 2.2B |
| IPO Year | 2013 | 2020 |
| Metric | AGIO | VERX |
|---|---|---|
| Price | $28.09 | $13.27 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 8 | 12 |
| Target Price | ★ $38.88 | $24.25 |
| AVG Volume (30 Days) | 856.8K | ★ 1.2M |
| Earning Date | 04-29-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | $43,011,000.00 | ★ $748,444,000.00 |
| Revenue This Year | $76.75 | $12.78 |
| Revenue Next Year | $170.73 | $11.61 |
| P/E Ratio | ★ N/A | $302.25 |
| Revenue Growth | N/A | ★ 12.25 |
| 52 Week Low | $22.24 | $10.59 |
| 52 Week High | $46.00 | $42.44 |
| Indicator | AGIO | VERX |
|---|---|---|
| Relative Strength Index (RSI) | 47.91 | 51.90 |
| Support Level | $26.42 | $11.38 |
| Resistance Level | $29.37 | $13.73 |
| Average True Range (ATR) | 0.94 | 0.78 |
| MACD | 0.16 | -0.02 |
| Stochastic Oscillator | 61.05 | 34.85 |
Agios Pharmaceuticals Inc is a biopharmaceutical company focused on the field of cellular metabolism to create differentiated medicines for rare diseases, with a focus on classical hematology. The company's primary focus is to develop potentially transformative small-molecule medicines. Its product candidate, Pyrukynd (mitapivat), is an activator of both wild-type and mutant pyruvate kinase enzymes, developed for the treatment of hemolytic anemias. The other drug candidates in its pipeline include Tebapivat (PK activator), being developed as a potential treatment for MDS-associated anemia and sickle cell disease, AG-181 (PAH stabilizer), AG-236 and others.
Vertex Inc is a provider of tax technology and services. Its software, content, and services help customers stay in compliance with indirect taxes that occur in taxing jurisdictions all over the world. It provides cloud-based and on-premise solutions to specific industries for every line of tax, including income, sales, consumer use, value-added, and payroll. The company offers solutions such as tax determination, Tax Data Management, document management, and compliance and reporting, among others. The company derives revenue from software subscriptions.